First Wave completes patient screening in trial of cystic fibrosis therapy

First Wave completes patient screening in trial of cystic fibrosis therapy

Source: 
Clinical Trials Arena
snippet: 

First Wave BioPharma has completed patient screening in its ongoing Phase II SPAN clinical trial of adrulipase for the treatment of exocrine pancreatic insufficiency (EPI) in cystic fibrosis (CF) patients.